DOACs and Kidney Dysfunction

59:20
Outpatient Anticoagulation Stewardship: Focusing on DOAC Management Models

1:06:27
Oral Anticoagulation for Atrial Fibrillation in Dialysis with Ziv Harel

34:33
Challenges of a podiatry practice scale up with Dr. Mikel Daniels

1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar

34:04
George Bakris, MD | Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

37:41
DOACs in Renal Dysfunction and Liver Disease

56:43
24. Attention and Awareness

1:01:00